New guidelines from two leading medical associations suggest that efforts to reduce bad cholesterol should focus on ...

A quantum tech firm that has collaborated with—and received investment from—Amgen is now planning to go public. Quantinuum was created in 2021 when industrial manufacturing juggernaut Honeywell spun ...

Guggenheim trimmed its price target (PT) on Amgen (NASDAQ:AMGN | AMGN Price Prediction) to $340 from $351 on Monday, May 4, ...

By Deena Beasley April 30 (Reuters) - Amgen on Thursday reported first-quarter product sales rose 4%, helped by demand for ...

Repatha’s withdrawal from Denmark is best understood as an early signal of the impact of Most Favored Nation drug pricing ...

Amgen has pulled the plug on midstage drug candidates for cancer and the autoimmune disease Sjögren’s syndrome, terminating ...

Earlier this year, when the FDA asked Amgen to pull its rare disease drug Tavneos from the market, the California drugmaker ...

Amgen CEO Robert Bradway has declared 2026 a “springboard year” for the California big biotech, in which the growth of its ...

May 4 (Reuters) - Amgen said on Monday it was investing an additional $300 million in Puerto Rico to expand its U.S.

Amgen (AMGN) stock dropped 1.54% as the biotech announced $300M for Puerto Rico expansion, part of a broader $3.65B+ U.S.

The FDA has renewed calls for Amgen’s Tavneos to be pulled from the market, saying it has discovered new evidence that study ...

Amgen on Thursday reported first-quarter product sales rose 4%, helped by demand for cholesterol and rare disease medicines, ...